“Bharatbook added a new report on "The Cardiovascular Market Outlook to 2015: Competitive landscape, global market analysis, key trends and pipeline analysis" into its market report catalogue for reselling. ...”

Cardiovascular Market has remained a leading therapy area in the global pharmaceutical market
Date:	Mon, 16 Aug 2010 06:37:39 GMT
Publisher:	Bharat Book Bureau
Web Site:	http://www.bharatbook.com
Email:	sandhya@bharatbook.com
Country:
Views:		1
Press Release:
The Cardiovascular Market Outlook to 2015: Competitive landscape, global market analysis, key trends and pipeline analysis The Cardiovascular Market Outlook to 2015 provides comprehensive coverage of the cardiovascular market, incorporating a disease overview and detailed epidemiological analyses of the major indications. This report makes a wide-ranging assessment of the marketed product portfolio, R and D pipeline, market share data, sales forecast and competitive landscape for the major players. Furthermore, it highlights the key market and R and D trends that may influence treatment sales; with a thorough analysis of the competitive dynamics of leading brands within each indication, in order to enable the reader to identify growing brands, key drug classes and leading players through 2015. ( http://www.bharatbook.com/detail.asp?id=134308 and rt=The-Cardiovascular-Market-Outlook-to-2015-Competitive-landscape-global-market-analysis-key-trends-and-pipeline-analysis.html ) The cardiovascular market may be segmented into numerous subcategories, including antihypertensives, antidyslipidemics, antithrombotics, cardiac therapies and other cardiovascular agents. While established treatments are currently available for each of these therapeutic subcategories, these markets are large and significant unmet medical needs still exists. Among the various cardiovascular indications, dyslipidemia had the highest prevalence in 2009, with approximately 333m people affected by the condition. The global cardiovascular market is quite dynamic and has remained a leading therapy area in the global pharmaceutical market. The seven major markets (7MM) captured a significant market share of the global cardiovascular market and also recorded a moderate Y-o-Y growth in 2009. The US continued to be a dominant market and registered a Y-o-Y increase in 2009, mainly attributed to the performance of key categories such as statins and beta blockers. In terms of pipeline developments, the thrombosis market has witnessed a lot of activity, with promising new drugs such as Sanofi-Aventis’ Multaq (launched in the US in 2009), J and J/Bayer’s Xarelto (launched in 2008), Pfizer/BMS’s apixaban (under registration), Eli Lilly/Daiichi Sankyo’s Effient (approved in 2009) and Boehringer Ingelheim’s Pradaxa (launched in 2008). These oral drugs are expected to widen the thrombosis market significantly, while also extending the prescription period. Additionally, these new generation drugs are set to undermine Lovenox’s (Sanofi-Aventis) monopoly in the thrombosis market. For more information kindly visit : http://www.bharatbook.com/detail.asp?id=134308 and rt=The-Cardiovascular-Market-Outlook-to-2015-Competitive-landscape-global-market-analysis-key-trends-and-pipeline-analysis.html Related Reports Global Cardiovascular Devices Market 2008-2012 http://www.bharatbook.com/detail.asp?id=129839 and rt=Global-Cardiovascular-Devices-Market-2008-2012.html India Cardiovascular Devices Market Outlook to 2016 http://www.bharatbook.com/detail.asp?id=140387 and rt=India-Cardiovascular-Devices-Market-Outlook-to-2016.html Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: http://twitter.com/3bbharatbook Please visit our blog at http://bharatbookseo.blogsome.com

Printer Friendly Version